RAQUEL ROMERO: Open Payments
NPI 1942873450 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 10 payments from 4 companies in 2025. Trend: 2023 $191 · 2024 $363 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $149 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Integra LifeSciences Corporation | 1 | $21 |
| GENZYME CORPORATION | 1 | $20 |
Products named: MOUNJARO, ZEPBOUND, NUCALA, ACCLARENT AERA, DUPIXENT.
Industry payments across CA — which companies pay providers there.
